Adenosine Dosing for FFR in the LAD
For FFR measurement in the left anterior descending artery, use intravenous adenosine at 140 μg/kg/min infused continuously for at least 2 minutes, or intracoronary adenosine at 160-200 μg as a bolus injection. 1, 2
Intravenous Administration (Standard Approach)
The FDA-approved and guideline-recommended dose is 140 μg/kg/min as a continuous peripheral intravenous infusion 1, 3. Key technical points:
- Infusion duration: Minimum 2 minutes to achieve steady-state maximal hyperemia 1
- Calculation: Total dose of 0.84 mg/kg over 6 minutes for myocardial perfusion imaging 3
- FFR measurement timing: Record the nadir of distal coronary pressure (Pd) during steady-state hyperemia 1
Critical Pitfall
Allow sufficient time (at least 60 seconds) for steady-state hyperemia to develop with IV adenosine 2. Premature measurement is a common source of error that can falsely elevate FFR values and miss functionally significant stenoses.
Intracoronary Administration (Alternative)
For the left coronary system (including LAD): 160-200 μg as a single bolus 2. This approach offers practical advantages:
- Faster: Achieves hyperemia in 23 seconds vs. 100 seconds for IV 4
- Better tolerated: 35% vs. 88% of patients report discomfort (IC vs. IV) 4
- Equivalent accuracy: Correlation r=0.99 with IV administration 4
Dose-Response Evidence
Research demonstrates that 80 μg may be insufficient for the LAD in many cases:
- Standard 80 μg missed 27% of significant stenoses (FFR <0.75) compared to higher doses 5
- 160-200 μg safely induces maximal hyperemia in the left coronary system 2
- Doses up to 400 μg have been studied but show no clinically relevant advantage over 160-200 μg 6
LAD-Specific Considerations
The LAD requires particular attention because:
- Larger myocardial territory: The LAD subtends more myocardium than other vessels, making accurate hyperemia critical 2
- Higher adenosine requirements: Left coronary system needs 2-2.5× the dose of the right coronary artery 2, 7
- Greater functional impact: LAD location independently predicts FFR values and functional significance 2
Practical Algorithm
Step 1: Choose route based on clinical scenario
- IV adenosine (140 μg/kg/min): When measuring multiple vessels or if patient has difficult venous access
- IC adenosine (160-200 μg): For single-vessel assessment, faster procedure time, or patient comfort priority
Step 2: If using IC adenosine and FFR is borderline (0.75-0.80)
- Consider repeat measurement with higher dose (up to 200 μg) to ensure maximal hyperemia 5, 7
- This reclassifies ~20% of borderline lesions to functionally significant 5
Step 3: Verify measurement quality
- Check for catheter damping (disengage if present) 1
- Confirm pressure signal drift <5 mmHg 1
- Ensure steady-state hyperemia achieved (stable Pd/Pa ratio) 1
Safety Profile
Both dosing strategies are safe when used appropriately:
- Transient AV block: Occurs in ~11% with high-dose IC adenosine, resolves spontaneously 5
- Contraindications: Avoid in second/third-degree AV block, sick sinus syndrome, or bronchospastic disease 3
- Higher doses (>200 μg IC): Increase patient discomfort without improving diagnostic accuracy 6
Evidence Quality Note
The 2012 Circulation consensus document 1 provides the foundational standardization, while the 2015 European Heart Journal guideline 2 incorporates newer dose-response data showing 160-200 μg is optimal for the left coronary system. Recent research (2023-2025) 8, 9 confirms that insufficient hyperemia remains a problem with standard dosing, supporting the higher end of the recommended range for the LAD.